Increase in Bioinformatics Research
Bioinformatics is the use of IT in biotechnology for the data storage, data warehousing and analyzing the DNA sequences. There are many applications of bioinformatics and its usage has been seen in Microbial genome applications, Molecular medicine, Personalized medicine, Preventative medicine, Gene therapy, Drug development, Antibiotic resistance, Evolutionary studies, Waste cleanup, Biotechnology and many other places. This has led to an increasing research in this field, which further requires the use of computational methods.
Also, increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug development and growth of drug designing, disease modeling and personalized medicine are some other drivers of the market.
Lack of Trained Professionals
Computational biology involves development and application of software, analytical and theoretical methods, mathematical modelling and other computational techniques used for study of biological, behavioral and social systems. This development and application requires use of trained professionals so as to make correct analysis. However, due to the lack of properly trained professionals hampers the market growth.
North America to Dominate the Market
The global computational biology market is segmented by drug type, therapeutic indication and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the market due to growing initiatives and investments for R&D of drug discovery, novel drugs, disease modeling, and technological advancements in biological computations.
Key Developments in the Market
- February 2018: Certara has recently acquired BaseCase, a Life Sciences Data Visualization company.
- February 2018: Schrödinger launched Cryo-EM Initiative (SCI) to develop breakthrough medicines using cryo-electron microscopy (Cryo-EM) technology.
Reasons to Purchase this Report
- Market analysis for the global computational biology market, with region-specific assessments and competition analysis on a global and regional scale.
- Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
- The treatment type that is expected to dominate the market
- Regions that are expected to witness fastest growth during the forecast period
- Identify the latest developments, market shares and strategies employed by the major market players
- 3-month analyst support along with the Market Estimate sheet (in Excel)
This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities And Challenges Analysis (Droc)
6.1 Market Drivers
6.1.1 Increase in Bioinformatics Research
6.1.2 Increasing Number of Clinical Studies in Pharmacogenomics and Pharmacokinetics
6.1.3 Growth of Drug Designing, Disease Modeling, and Personalized Medicine
6.2 Market Restraints
6.2.1 Lack of Trained Professional
6.4 Key Challenges
7. Market Segmentation
7.1 By Application
7.1.1 Cellular & Biological Simulation
188.8.131.52 Computational Genomics
184.108.40.206 Computational Proteomics
220.127.116.11 Other Cellular and Biological Simulations (Transcriptomics/Metabolomics)
7.1.2 Drug Discovery and Disease Modelling
18.104.22.168 Target Identification
22.214.171.124 Target Validation
126.96.36.199 Lead Discovery
188.8.131.52 Lead Optimization
7.1.3 Preclinical Drug Development
7.1.4 Clinical Trials
184.108.40.206 Phase I
220.127.116.11 Phase II
18.104.22.168 Phase III
7.1.5 Human Body Simulation Software
7.2 By Tools
7.2.3 Analysis Software & Services
7.3 By Services
7.4 By End - User
7.5 By Geography
7.5.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of APAC
7.5.4 Middle East & Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East & Africa
7.5.5 South America
126.96.36.199 Rest of South America
8. Competitive Landscape
8.1 Mergers And Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches
9. Key Players
9.1 Dassault Systemes
9.3 Chemical Computing Group Inc.
9.4 Compugen Ltd
9.5 Rosa & Co. LLC (Acquired Entelos)
9.6 Genedata AG
9.7 Insilico Biotechnology AG
9.8 Leadscope Inc
9.9 Nimbus Discovery Llc
9.10 Strand Life Sciences
9.12 Simulation Plus Inc
10. Future of the Market
- Dassault Systemes
- Chemical Computing Group Inc.
- Compugen Ltd
- Rosa & Co LLC
- Genedata AG
- Insilico Biotechnology AG
- Leadscope Inc
- Nimbus Discovery LLC
- Strand Life Sciences
- Simulation Plus Inc.